SMARCD3 and neoplasm: Consistently, overexpression (OE) of SMARCD3 in D425 cells increased cell migration, spinal metastasis and the percentage of tumour-bearing mice with CTCs (Fig. 2i–k and Extended Data Fig. 2h,i).